Perceptive Advisors LLC Axonics, Inc. Transaction History

Perceptive Advisors LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$39.5 - $64.42 $13.5 Million - $22 Million	-341,211 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$43.74 - $62.76 $14.9 Million - $21.4 Million	341,211 New	341,211 $21.4 Million
Q2 2020 Aug 14, 2020	SELL	$22.91 - $39.83 $1.15 Million - $1.99 Million	-50,000 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$16.44 - $37.73 $82,200 - $188,649	-5,000 Reduced 9.09%	50,000 $1.19 Million
Q4 2019 Feb 14, 2020	BUY	$19.57 - $28.96 $1.08 Million - $1.59 Million	55,000 New	55,000 $1.52 Million
Q3 2019 Nov 14, 2019	SELL	$26.92 - $42.41 $7.69 Million - $12.1 Million	-285,502 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$18.54 - $40.97 $7.42 Million - $16.4 Million	-400,254 Reduced 58.37%	285,502 $11.7 Million
Q1 2019 May 15, 2019	SELL	$13.32 - $24.35 $869,050 - $1.59 Million	-65,244 Reduced 8.69%	685,756 $16.4 Million
Q4 2018 Feb 14, 2019	BUY	$13.2 - $16.43 $9.91 Million - $12.3 Million	751,000 New	751,000 $10.9 Million

241

42.8M

73.7K

230K

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.41B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Perceptive Advisors LLC with notifications on news.